Lobbying

Jazz Pharmaceuticals JAZZ's latest lobbying report covers Q2 2026, at $720K. The four quarters Q4 2025–Q3 2026 total $2.1M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.

Jazz PharmaceuticalsJAZZ

Jazz Pharmaceuticals stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$2.1M
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Jazz Pharmaceuticals lobbying by quarter
Jazz Pharmaceuticals lobbying by quarter
QuarterAmountReports
Q4 2022$880K5
Q1 2023$870K5
Q2 2023$880K5
Q3 2023$880K5
Q4 2023$930K5
Q1 2024$660K5
Q2 2024$670K4
Q3 2024$650K4
Q4 2024$720K4
Q1 2025$560K4
Q2 2025$550K4
Q3 2025$590K4
Q4 2025$700K5
Q1 2026$700K5
Q2 2026$720K5
Q3 2026$00

By issue

  • Pharmacy$7.9M · 15 reports
  • Health issues$2M · 50 reports
  • Medicare and Medicaid$423.3K · 14 reports
  • Budget and appropriations$333.3K · 21 reports
  • Medical research and clinical labs$266.7K · 15 reports
  • Trade$25K · 1 reports
  • Defense$16.7K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • SENATE64 reports
  • HOUSE OF REPRESENTATIVES62 reports
  • Food & Drug Administration (FDA)14 reports
  • White House Office6 reports
  • Health & Human Services, Dept of (HHS)5 reports
  • Office of Management & Budget (OMB)4 reports
  • Centers For Medicare and Medicaid Services (CMS)3 reports
  • Executive Office of the President (EOP)3 reports
  • Natl Credit Union Administration (NCUA)1 reports
  • Treasury, Dept of1 reports
  • U.S. Trade Representative (USTR)1 reports

Firms it paid

Firm
In-houseJazz Pharmaceuticals$7.9M15 quarters
Tarplin, Downs & Young$1.1M15 quarters
Avenue Solutions$900K15 quarters
Tiber Creek Group$800K15 quarters
The Nickles Group$130K3 quarters
Olsson, Frank, Weeda, Terman & Matz, PC$100K6 quarters

Former officials lobbying for it

Former position
MOLLY FROMM(continued) U.S. House Cmte on Oversight and Government Reform, Deputy General Counsel, Parliamentarian, Professional Staff Member; U.S. Rep. Darrell Issa, Leg. Asst., Leg. Corr., Staff Asst., InternQ2 2026
PARICK BRAERTON CARROLLLeg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte.Q2 2026
RAISSA H DOWNSPrin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.Q2 2026
CHARLOTTE SPEARS IVANCICLegislative Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Committee; Asst. to the Speaker for Policy, Speaker John BoehnerQ3 2025
ELIZABETH T MURRAYSenior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob GrahamQ3 2025
EMILY H MURRYStaff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom PriceQ3 2025
JENNIFER B YOUNGAsst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on FinanceQ3 2025
LAURA FRIEDELLeg. Asst., Sen. Zell Miller, Leg. Dir., Sen. Richard Shelby, Clerk, Staff Dir., Sen. Appropriations CommitteeQ3 2025
MARGARET JOSEPHCoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte.Q3 2025
PAMELA SMITHLeg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-BraunQ3 2025
PETER FISEHealth Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government ReformQ3 2025
MATTHEW FUENTESLA - Senate Democratic Minority Leader Sen. Chuck Schumer; LA - Senate Democratic Majority Leader Sen. Chuck Schumer; Legislative Aide - Sen. Chuck Schumer; Research Assistant - Senate Finance Committee (Sen. Ron Wyden)Q2 2025
KIMBERLY LYNN BRANDTSr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on FinanceQ4 2024
ROGER R SZEMRAJHouse Approps Comm; CoS Rep. Marcy KapturQ4 2023
MICHELLE P EASTONChief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy TauzinQ4 2022

Lobbying reports

Filed by
07/20for Q2Tarplin, Downs & Young$80K
07/20for Q2In-house$490K
07/20for Q2Avenue Solutions$50K
07/20for Q2The Nickles Group$50K
07/19for Q2Tiber Creek Group$50K
04/20for Q1Avenue Solutions$50K
04/20for Q1In-house$470K
04/20for Q1Tarplin, Downs & Young$80K
04/20for Q1Tarplin, Downs & Young$80K
04/20for Q1The Nickles Group$50K
04/18for Q1Tiber Creek Group$50K
01/20for Q4 2025Tarplin, Downs & Young$80K
01/20for Q4 2025Avenue Solutions$50K
01/20for Q4 2025The Nickles Group$30K
01/17for Q4 2025Tiber Creek Group$50K
01/16for Q4 2025In-house$490K
25/12/01for Q4 2025The Nickles GroupUnder $5,000
25/10/20for Q3 2025Avenue Solutions$50K
25/10/19for Q3 2025Tiber Creek Group$50K
25/10/17for Q3 2025In-house$410K